Retraction and republication-Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study

Lancet Oncol. 2023 Aug;24(8):832. doi: 10.1016/S1470-2045(23)00327-3. Epub 2023 Jul 14.
No abstract available

Publication types

  • Retraction of Publication